Literature DB >> 17823249

Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis.

Arturo Hernandez1, M Elena Martinez, Xiao-Hui Liao, Jacqueline Van Sande, Samuel Refetoff, Valerie Anne Galton, Donald L St Germain.   

Abstract

The type 3 deiodinase (D3) is a selenoenzyme that inactivates thyroid hormones and is highly expressed during development and in the adult central nervous system. We have recently observed that mice lacking D3 activity (D3KO mice) develop perinatal thyrotoxicosis followed in adulthood by a pattern of hormonal levels that is suggestive of central hypothyroidism. In this report we describe the results of additional studies designed to investigate the regulation of the thyroid axis in this unique animal model. Our results demonstrate that the thyroid and pituitary glands of D3KO mice do not respond appropriately to TSH and TRH stimulation, respectively. Furthermore, after induction of severe hypothyroidism by antithyroid treatment, the rise in serum TSH in D3KO mice is only 15% of that observed in wild-type mice. In addition, D3KO animals rendered severely hypothyroid fail to show the expected increase in prepro-TRH mRNA in the paraventricular nucleus of the hypothalamus. Finally, treatment with T(3) results in a serum T(3) level in D3KO mice that is much higher than that in wild-type mice. This is accompanied by significant weight loss and lethality in mutant animals. In conclusion, the absence of D3 activity results in impaired clearance of T(3) and significant defects in the mechanisms regulating the thyroid axis at all levels: hypothalamus, pituitary, and thyroid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823249     DOI: 10.1210/en.2007-0652

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  42 in total

1.  Reduced Sensitivity to Thyroid Hormone as a Transgenerational Epigenetic Marker Transmitted Along the Human Male Line.

Authors:  João Anselmo; Neal H Scherberg; Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Thyroid       Date:  2019-05-09       Impact factor: 6.568

Review 2.  Reawakened interest in type III iodothyronine deiodinase in critical illness and injury.

Authors:  Stephen A Huang; Antonio C Bianco
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-01-22

Review 3.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 4.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 5.  Understanding selenoprotein function and regulation through the use of rodent models.

Authors:  Marina V Kasaikina; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Biochim Biophys Acta       Date:  2012-03-13

6.  Adult onset of type 3 deiodinase deficiency in mice alters brain gene expression and increases locomotor activity.

Authors:  J Patrizia Stohn; M Elena Martinez; Donald L St Germain; Arturo Hernandez
Journal:  Psychoneuroendocrinology       Date:  2019-09-18       Impact factor: 4.905

7.  Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X).

Authors:  Caterina Di Cosmo; Neil McLellan; Xiao-Hui Liao; Kum Kum Khanna; Roy E Weiss; Laura Papp; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

Review 8.  Thyroid hormone and the brain: Mechanisms of action in development and role in protection and promotion of recovery after brain injury.

Authors:  Yan-Yun Liu; Gregory A Brent
Journal:  Pharmacol Ther       Date:  2018-02-09       Impact factor: 12.310

Review 9.  The syndrome of inherited partial SBP2 deficiency in humans.

Authors:  Alexandra M Dumitrescu; Caterina Di Cosmo; Xiao-Hui Liao; Roy E Weiss; Samuel Refetoff
Journal:  Antioxid Redox Signal       Date:  2010-04-01       Impact factor: 8.401

10.  Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease.

Authors:  Charlene M Downey; Chelsea R Horton; Bradley A Carlson; Trish E Parsons; Dolph L Hatfield; Benedikt Hallgrímsson; Frank R Jirik
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.